Cambridge Cognition Holdings (COG)

Sector:

Health Care

Index:

FTSE AIM All-Share

56.20p
   
  • Change Today:
      1.20p
  • 52 Week High: 104.00
  • 52 Week Low: 48.80
  • Currency: UK Pounds
  • Shares Issued: 34.96m
  • Volume: 21,504
  • Market Cap: £19.65m
  • RiskGrade: 282

Cambridge Cognition finds local partner for China expansion

By Josh White

Date: Thursday 24 Nov 2022

LONDON (ShareCast) - (Sharecast News) - Brain health technology developer Cambridge Cognition announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare on Thursday.
The AIM-traded firm said it signed an exclusive licence agreement with Luca to commercialise its suite of cognitive assessment tools in China, for both the pharmaceutical and healthcare markets.

It said the partnership would provide it with an "efficient and low-risk" geographic expansion, while leveraging its recent projects to go live in an Amazon Web Services (AWS) data centre in China, and implement a range of Chinese languages.

Cambridge Cognition would be paid through a mix of milestone payments and royalties.

As well as a commercial licence, the partnership included the opportunity to collaborate on co-developments to improve the solutions of both companies.

The board described China as the second-most active clinical trial market in the world after the United States, having hosted nearly 10,000 industry-sponsored trials in the last five years, with 14% being in central nervous system conditions.

It said the healthcare market opportunity in China for cognitive impairment diagnostics could also be considerable, with nearly 40 million people affected by mild cognitive impairment and nearly 10 million living with Alzheimer's disease.

Cambridge Cognition said it had been "laying the groundwork" to successfully capitalise on the "significant" market opportunity since 2019, by establishing a dedicated service in the region, delivered from a secure cloud infrastructure provided by AWS.

It also developed task variants in the most commonly-spoken languages of Cantonese and Mandarin, and the written language of simplified Chinese, and built on an existing relationship with Fudan University in Shanghai.

"The Chinese pharmaceutical and healthcare markets offer a significant commercial opportunity for Cambridge Cognition, and we have partnered with Luca Healthcare to capitalise on this," said chief executive officer Matthew Stork.

"The team at Luca Healthcare have impressed us with their speed to commercialise other digital healthcare solutions, working with leading pharmaceutical companies in the region and, as a result, building a fast growth business."

At 1236 GMT, shares in Cambridge Cognition Holdings were up 6.04% at 127.25p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

COG Market Data

Currency UK Pounds
Share Price 56.20p
Change Today 1.20p
% Change 2.18 %
52 Week High 104.00
52 Week Low 48.80
Volume 21,504
Shares Issued 34.96m
Market Cap £19.65m
RiskGrade 282

COG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.17% below the market average68.17% below the market average68.17% below the market average68.17% below the market average68.17% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
69.83% below the market average69.83% below the market average69.83% below the market average69.83% below the market average69.83% below the market average
18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average18.92% below the sector average
Income Not Available
Growth
34.75% above the market average34.75% above the market average34.75% above the market average34.75% above the market average34.75% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

COG Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 1,500 @ 56.20p
16:35 1,500 @ 56.20p
15:47 1,754 @ 54.00p
15:44 150 @ 54.74p
15:40 19 @ 55.00p

COG Key Personnel

Chair Steven John Powell
CEO Matthew Stork
CFO Stephen Symonds

Top of Page